Adia Med Inc (ADIA)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
Jun 15, 2026, 9:30 AM EST
Adia Med Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 |
| 0.81 | 0.7 | 0.01 | - | 0.2 | 0.76 | |
Revenue Growth (YoY) | 58.73% | 10879.75% | - | - | -74.03% | 83.23% |
Cost of Revenue | 0.57 | 0.52 | 0 | - | 0.15 | 0.43 |
Gross Profit | 0.24 | 0.18 | 0 | - | 0.05 | 0.33 |
Selling, General & Admin | 0.55 | 0.47 | 0.15 | 0 | 4.3 | 0.83 |
Research & Development | 0.04 | 0.04 | - | - | 1.78 | 0.07 |
Operating Expenses | 0.64 | 0.55 | 0.18 | 0 | 6.09 | 0.9 |
Operating Income | -0.41 | -0.36 | -0.17 | -0 | -6.04 | -0.58 |
Interest Expense | -0.04 | -0.03 | -0.01 | - | -0.06 | -0.02 |
Interest & Investment Income | 0 | 0 | - | - | 0 | 0 |
Other Non Operating Income (Expenses) | - | - | - | - | -1.24 | - |
EBT Excluding Unusual Items | -0.44 | -0.4 | -0.18 | -0 | -7.33 | -0.6 |
Merger & Restructuring Charges | - | - | - | - | -1.28 | - |
Pretax Income | -0.44 | -0.4 | -0.18 | -0 | -8.61 | -0.6 |
Income Tax Expense | - | - | - | - | 0 | 0 |
Net Income | -0.44 | -0.4 | -0.18 | -0 | -8.61 | -0.6 |
Net Income to Common | -0.44 | -0.4 | -0.18 | -0 | -8.61 | -0.6 |
Shares Outstanding (Basic) | 93 | 94 | 92 | 88 | 24 | 15 |
Shares Outstanding (Diluted) | 93 | 94 | 92 | 88 | 24 | 15 |
Shares Change (YoY) | 222.03% | 2.03% | 4.36% | 269.20% | 63.30% | - |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.36 | -0.04 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.36 | -0.04 |
Free Cash Flow | -0.22 | -0.19 | -0.36 | -0 | -3.99 | -0.31 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | - | -0.17 | -0.02 |
Gross Margin | 29.34% | 26.22% | 34.39% | - | 24.42% | 42.88% |
Operating Margin | -50.42% | -52.03% | -2739.01% | - | -3059.73% | -75.70% |
Profit Margin | -54.88% | -56.45% | -2838.04% | - | -4362.65% | -78.55% |
Free Cash Flow Margin | -27.55% | -27.47% | -5600.42% | - | -2020.45% | -41.37% |
EBITDA | -0.38 | -0.34 | -0.17 | - | -5.92 | -0.56 |
EBITDA Margin | -46.89% | -48.28% | - | - | - | -73.46% |
D&A For EBITDA | 0.03 | 0.03 | 0 | - | 0.12 | 0.02 |
EBIT | -0.41 | -0.36 | -0.17 | -0 | -6.04 | -0.58 |
EBIT Margin | -50.42% | -52.03% | - | - | - | -75.70% |
Revenue as Reported | 0.81 | 0.7 | 0.01 | - | 0.2 | 0.76 |
Advertising Expenses | - | 0.08 | 0.04 | - | 0.01 | 0.01 |